Publications are one measure of the quality of a study and its data. SABER biostatisticians have led analytic efforts for studies that have been published in top-tier medical journals such as The New England Journal of Medicine, The Journal of the American Medical Association, and The Lancet.

Stent Vs. Indomethacin For Preventing Post-ERCP Pancreatitis (SVI)

1. Elmunzer BJ, Serrano J, Chak A, Edmundowicz SA, Papachristou GI, Scheiman JM, Singh VK, Varadurajulu S, Vargo JJ, Willingham FF. Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial. Trials. 2016;17(1):120.

A Randomized, Double-Blinded, Placebo-Controlled Trial Of Corticosteroid Therapy Following Portoenterostomy In Infants With Biliary Atresia (START)

1. Venkat VL, Shneider BL, Magee JC, Turmelle Y, Arnon R, Bezerra JA, Hertel PM, Karpen SJ, Kerkar N, Loomes KM. Total serum bilirubin predicts fat-soluble vitamin deficiency better than serum bile acids in infants with biliary atresia. Journal of pediatric gastroenterology and nutrition. 2014;59(6):702.
2. Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Wang KS, Erlichman J, Haber B, Hertel PM, Karpen SJ. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. Jama. 2014;311(17):1750-9.
3. Shneider BL, Magee JC, Bezerra JA, Haber B, Karpen SJ, Raghunathan T, Rosenthal P, Schwarz K, Suchy FJ, Kerkar N. Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics. 2012;130(3):e607-e14.

Preventing Urinary Tract Infection Post Surgery – A Double-Blind, Placebo-Controlled Study Of The Effect Of Cranberry Capsules (PUPS)

1. Foxman B, Cronenwett AE, Spino C, Berger MB, Morgan DM. Cranberry juice capsules and urinary tract infection after surgery: results of a randomized trial. American journal of obstetrics and gynecology. 2015;213(2):194
2. Marschall J, Piccirillo ML, Foxman B, Zhang L, Warren DK, Henderson JP. Patient characteristics but not virulence factors discriminate between asymptomatic and symptomatic E. coli bacteriuria in the hospital. BMC infectious diseases. 2013;13(1):213.
3. Marschall J, Zhang L, Foxman B, Warren DK, Henderson JP. Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients. Clinical infectious diseases. 2012;54(12):1692-8.

Randomized Evaluation of VAD InterVEntion before Inotropic Therapy (REVIVE-IT) Pilot Trial (REVIVE-IT)

1. Baldwin JT, Mann DL. NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial. Journal of cardiac failure. 2010;16(11):855-8.
2. Pagani FD, Aaronson KD, Kormos R, Mann DL, Spino C, Jeffries N, Taddei-Peters WC, Mancini DM, McNamara DM, Grady KL. The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapy. Elsevier; 2016.

Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors

1. Maestas MM, Brook RD, Ziemba RA, Li F, Crane RC, Klaver ZM, Bard RL, Spino CA, Adar SD, Morishita M. Reduction of personal PM2.5 exposure via indoor air filtration systems in Detroit: an intervention study. Journal of Exposure Science and Environmental Epidemiology (accepted) (2018).

Pessary vs behavioral therapy - ATLAS (PFDN-ATLAS)

1. Borello-France D, Burgio KL, Goode PS, Ye W, Weidner AC, Lukacz ES, Jelovsek J-E, Bradley CS, Schaffer J, Hsu Y. Adherence to behavioral interventions for stress incontinence: rates, barriers, and predictors. Physical therapy. 2013;93(6):757.
2. Kenton K, Barber M, Wang L, Meikle S, Hsu Y, Rahn D, Whitcomb E, Amundsen C, Bradley C, Zyczynski H. Pelvic floor symptoms improve similarly after pessary and behavioral treatment for stress incontinence. Female pelvic medicine & reconstructive surgery. 2012;18(2):118.
3. Schaffer J, Nager CW, Xiang F, Borello-France D, Bradley CS, Wu JM, Mueller E, Norton P, Paraiso MFR, Zyczynski H. Predictors of success and satisfaction of nonsurgical therapy for stress urinary incontinence. Obstetrics and gynecology. 2012;120(1):91.

CARE: Colpopexy And urinary Reduction Efforts (PFDN-CARE)

1. Jelovsek JE, Chagin K, Brubaker L, Rogers RG, Richter HE, Arya L, Barber MD, Shepherd JP, Nolen TL, Norton P. A model for predicting the risk of de novo stress urinary incontinence in women undergoing pelvic organ prolapse surgery. Obstetrics and gynecology. 2014;123(2 0 1):279.
2. Gutman RE, Nygaard IE, Ye W, Rahn DD, Barber MD, Zyczynski HM, Rickey L, Nager CW, Varner RE, Kenton K. The Pelvic Floor Complication Scale: a new instrument for reconstructive pelvic surgery. American journal of obstetrics and gynecology. 2013;208(1):81. e1-. e9.

Extended Colpopexy And Urinary Reduction Efforts (PFDN-E-CARE)

1. Grimes C, Lukacz ES, Gantz MG, Warren LK, Brubaker L, Zyczynski HM, Richter HE, Jelovsek JE, Cundiff G, Fine P. What happens to the posterior compartment and bowel symptoms after sacrocolpopexy? evaluation of 5-year outcomes from E-CARE. Female pelvic medicine & reconstructive surgery. 2014;20(5):261.
2. Nygaard I, Brubaker L, Zyczynski HM, Cundiff G, Richter H, Gantz M, Fine P, Menefee S, Ridgeway B, Visco A. Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse. Jama. 2013;309(19):2016-24. 

Outcomes Following Vaginal Prolapse Repair and mid urethral sling (opus) trial (PFDN-OPUS)

1. Brubaker L, Nager CW, Richter HE, Weidner AC, Hsu Y, Wai CY, Paraiso M, Nolen TL, Wallace D, Meikle S. Effectiveness of blinding: sham suprapubic incisions in a randomized trial of retropubic midurethral sling in women undergoing vaginal prolapse surgery. American journal of obstetrics and gynecology. 2014;211(5):554. e1-. e7.
2. Wei JT, Nygaard I, Richter HE, Nager CW, Barber MD, Kenton K, Amundsen CL, Schaffer J, Meikle SF, Spino C. A midurethral sling to reduce incontinence after vaginal prolapse repair. New England Journal of Medicine. 2012;366(25):2358-67.

BOOST: Behavioral Therapy Of Obstetric Sphincter Tears (PFDN-BOOST)

1. Mueller ER, Corton M, Fielding J, Spino C, Jelovsek JE, Weidner A, Zyczynski H, Menefee S, Gantz MG, Tuteja A, Richter HE, Pelvic Floor Disorders Network. Results of a Novel and Comprehensive Training Program for Standardization of 2-Dimensional Ultrasound Interpretation as a Precursor to a Multicenter Trial JJ Med Diagnosis and Image. 2016 May; 1(1): 012.
2. Richter HE, Nager CW, Burgio KL, Whitworth R, Weidner AC, Schaffer J, Zyczynski HM, Norton P, Jelovsek JE, Meikle SF, Spino C, Gantz M, Graziano S, Brubaker L, Network NPFD. Incidence and Predictors of Anal Incontinence After Obstetric Anal Sphincter Injury in Primiparous Women. Female Pelvic Med Reconstr Surg. 2015;21(4):182-9. doi: 10.1097/SPV.0000000000000160. PubMed PMID: 25679358; PMCID: PMC4481184.

Operations and Pelvic Muscle Training in the Management of Apical Support Loss: The OPTIMAL Trial (PFDN-OPTIMAL)

1. Lukacz ES, Warren LK, Richter HE, Brubaker L, Barber MD, Norton P, Weidner AC, Nguyen JN, Gantz MG. Quality of Life and Sexual Function 2 Years After Vaginal Surgery for Prolapse. Obstetrics & Gynecology. 2016;127(6):1071-9.
2. Barber MD, Brubaker L, Burgio KL, Richter HE, Nygaard I, Weidner AC, Menefee SA, Lukacz ES, Norton P, Schaffer J. Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. Jama. 2014;311(10):1023-34.
3. Barber MD, Kenton K, Janz NK, Hsu Y, Dyer KY, Greer WJ, White A, Meikle S, Ye W. Validation of the activities assessment scale in women undergoing pelvic reconstructive surgery. Female pelvic medicine & reconstructive surgery. 2012;18(4):205.
4. Barber MD, Janz N, Kenton K, Hsu Y, Greer WJ, Dyer K, White A, Meikle S, Ye W. Validation of the surgical pain scales in women undergoing pelvic reconstructive surgery. Female pelvic medicine & reconstructive surgery. 2012;18(4):198.

Anticholinergic vs. Botox Comparison study: The ABC Trial (PFDN-ABC)

1. Visco AG, Zyczynski H, Brubaker L, Nygaard I, Xu X, Lukacz ES, Paraiso MF, Greer J, Rahn DD, Meikle SF. Cost-Effectiveness Analysis of Anticholinergics Versus Botox for Urgency Urinary Incontinence: Results From the Anticholinergic Versus Botox Comparison Randomized Trial. Female Pelvic Medicine & Reconstructive Surgery. 2016;22(5):311-6.
2. Visco AG, Brubaker L, Jelovsek JE, Wilson TS, Norton P, Zyczynski HM, Spino C, Sirls L, Nguyen JN, Rahn DD. Adherence to oral therapy for urgency urinary incontinence: results from the Anticholinergic versus Botox Comparison (ABC) trial. Female pelvic medicine & reconstructive surgery. 2016;22(1):24-8.
3. Pearce MM, Zilliox MJ, Rosenfeld AB, Thomas-White KJ, Richter HE, Nager CW, Visco AG, Nygaard IE, Barber MD, Schaffer J. The female urinary microbiome in urgency urinary incontinence. American journal of obstetrics and gynecology. 2015;213(3):347. e1-. e11.
4. Brubaker L, Nager CW, Richter HE, Visco A, Nygaard I, Barber MD, Schaffer J, Meikle S, Wallace D, Shibata N. Urinary bacteria in adult women with urgency urinary incontinence. International urogynecology journal. 2014;25(9):1179-84.
5. Visco AG, Brubaker L, Richter HE, Nygaard I, Paraiso MFR, Menefee SA, Schaffer J, Lowder J, Khandwala S, Sirls L. Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. New England Journal of Medicine. 2012;367(19):1803-13.
6. Visco AG, Brubaker L, Richter HE, Nygaard I, Paraiso MF, Menefee SA, Schaffer J, Wei J, Chai T, Janz N. Anticholinergic versus botulinum toxin A comparison trial for the treatment of bothersome urge urinary incontinence: ABC trial. Contemporary clinical trials. 2012;33(1):184-96.